Industry: Healthcare | Lastest Edition: February 26, 2026 | No of Pages: 128 | No. of Tables: 95 | No. of Figures: 48 | Format: PDF | Report Code : HC1272
The South Korea Dialysis Market size was valued at USD 453.4 million in 2024 and is expected to reach USD 533.9 million by 2025. Looking ahead, the market is projected to expand significantly, reaching USD 873.6 million by 2030 at a CAGR of 10.35% from 2025 to 2030.
The market is experiencing steady growth, driven by the rising prevalence of chronic kidney disease (CKD), diabetes, and hypertension, alongside an aging population and increasing lifestyle-related health risks. Innovations in hemodialysis and peritoneal dialysis technologies are enhancing treatment effectiveness, patient comfort, and overall outcomes. The expansion of home-based dialysis therapies, supported by telehealth monitoring, is improving accessibility and convenience for patients. Additionally, government-backed healthcare initiatives and public programs are facilitating broader adoption of dialysis services. Collectively, these factors are accelerating market growth while promoting more efficient, patient-centric, and technologically advanced renal care across South Korea.
South Korea is witnessing increased adoption of automated dialysis machines and connected systems equipped with AI-assisted monitoring. These technologies improve treatment accuracy, enhance patient safety, and optimize therapy schedules. Integration with digital platforms allows clinicians to manage patients remotely and detect early complications. Continuous innovation in wearable and portable dialysis devices is further boosting market demand, making treatment more accessible and patient-friendly.
In South Korea, home-based dialysis therapies are gaining momentum, particularly among elderly and urban populations. Telehealth-enabled monitoring allows healthcare providers to supervise treatments remotely, adjust schedules, and intervene promptly in case of complications. Government-backed reimbursement programs and awareness campaigns are encouraging patients to adopt home-based care, reducing hospital visits and enhancing convenience. This shift toward patient-centered care is significantly driving market growth, expanding the reach of dialysis services across the country.
A major challenge in South Korea’s dialysis market is the limited availability of trained nephrologists, dialysis nurses, and technicians, particularly in semi-urban and rural regions. Advanced dialysis technologies, including home-based and automated systems, require skilled personnel to operate and monitor treatments safely. The shortage of qualified staff can delay adoption of modern equipment, reduce treatment efficiency, and create regional disparities in access. Hospitals and clinics may struggle to scale services despite growing demand, which constrains overall market growth.
The dialysis market in South Korea has significant opportunities arising from the development of portable and wearable dialysis devices, which allow patients to manage treatments with greater independence. Simultaneously, the growth of private dialysis centers and specialty renal care clinics enhances access to advanced therapies, particularly in urban regions. Collaborations between medical device companies and healthcare providers facilitate the introduction of AI-assisted and connected systems, improving treatment efficiency and patient convenience. These innovations support patient-centred care, reduce hospital dependency, and create new revenue streams for providers, offering substantial potential for South Korea dialysis market expansion in the country’s technologically advanced dialysis sector.
The market players operating in the South Korea dialysis industry include Fresenius Medical Care AG & Co. KGaA, Baxter International Inc., B. Braun, Asahi Kasei Corporation, Becton, Dickinson and Company, Toray Medical Co., Ltd., Terumo Corporation, JMS Co. Ltd., W. L. Gore & Associates, Inc., Teleflex Incorporated, Quanta Dialysis Technologies Ltd, Vantive Health LLC, and Medionics International Inc.
Hemodialysis (HD)
Hemodialysis Machines
In-center HD
Home HD
Water Treatment Systems
Central water-disinfection units
Point-of-use/portable systems
Ancillary/Other HD Equipment
UF/ultrafiltration pumps
Dialysis chairs/beds
Disinfection/sterilization units
Monitoring & data-capture hardware
HD Consumables & Supplies
Dialyzers
Bloodlines & Tubing Sets
Dialysis Fluids / Concentrates
Vascular Access Products
Other HD Consumables & Accessories
HD Aftermarket Services
Repair & Maintenance
Installation & Commissioning
Training & Technical Support
Peritoneal Dialysis (PD)
PD Cyclers / Automated PD Machines
Ancillary PD Equipment
PD Consumables & Supplies
PD Dialysis Solutions
PD Catheters & Access Systems
Transfer Sets & Tubing
Other PD Supplies / Accessories
PD Aftermarket Services
Repair & Maintenance (Cyclers & Heaters)
Installation & Commissioning
Training & Technical Support
Hospitals
Dialysis Centers
Homecare
Ambulatory Surgical Centers
B Braun
Asahi Kasei Corporation
Becton, Dickinson and Company
Toray Medical Co,.Ltd.
Terumo Corporation
JMS Co. Ltd.
W. L. Gore & Associates, Inc.
Teleflex Incorporated
Quanta Dialysis Technologies Ltd
Vantive Health LLC
Medionics International Inc.
|
Parameters |
Details |
|
Market Size in 2025 |
USD 533.9 Million |
|
Revenue Forecast in 2030 |
USD 873.6 Million |
|
Growth Rate |
CAGR of 10.3% from 2025 to 2030 |
|
Analysis Period |
2024–2030 |
|
Base Year Considered |
2024 |
|
Forecast Period |
2025–2030 |
|
Market Size Estimation |
Million (USD) |
|
Growth Factors |
|
|
Companies Profiled |
13 |
|
Market Share |
Available for 10 companies |
|
Customization Scope |
Free customization (equivalent up to 80 working hours of analysts) after purchase. Addition or alteration to country, regional, and segment scope. |
|
Pricing and Purchase Options |
Avail customized purchase options to meet your exact research needs. |